chemistry

IHCH-8110

IHCH-8110 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand IHCH-8110 rather than just read about it. In short: IHCH-8110 is a peripherally selective and non-hallucinogenic serotonin 5-HT2A receptor agonist. Pharmacology IHCH-8110 shows affinity for the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors (Ki = 48 nM, 102 nM, and 302 nM, respectively).

Key takeaways

IHCH-8110 belongs to chemistry; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect IHCH-8110 to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of IHCH-8110 from memory before moving on to harder problems.

Reference excerpt

IHCH-8110 is a peripherally selective and non-hallucinogenic serotonin 5-HT2A receptor agonist.

Pharmacology IHCH-8110 shows affinity for the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors (Ki = 48 nM, 102 nM, and 302 nM, respectively). The drug is a partial agonist at the serotonin 5-HT2A receptor with an EC50Tooltip half-maximal effective concentration of 93–479 nM and EmaxTooltip maximal efficacy of 45–68%. It is also a partial agonist of the serotonin 5-HT2C receptor but not of the serotonin 5-HT2B receptor, where it instead functioned as an antagonist. The drug did not interact with other serotonin or dopamine receptors. IHCH-8110 is highly peripherally selective and does not produce the head-twitch response, a behavioral proxy of psychedelic effects, nor affect locomotor activity in rodents. It has been found to enhance CD8+ T cell-mediated antitumor immunity and inflammation and to suppress colorectal cancer progression, effects mediated by activation of serotonin 5-HT2A receptors on enteric glial cells that results in increased CXCL10 and interleukin-18 expression.

Chemistry The chemical synthesis of IHCH-8110 has been described.

History IHCH-8110 was first described in the scientific literature by YaTing Wen and colleagues in 2026. It was developed following observations of the psychedelic drug LSD having similar colonic effects. There is interest in IHCH-8110 for potential medical use in colorectal cancer immunotherapy.

See also Serotonin 5-HT2A receptor agonist List of miscellaneous 5-HT2A receptor agonists

References

Illustrations

Worked examples

Example 1 — a first encounter with IHCH-8110

Start with the simplest possible case. Write down what IHCH-8110 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to IHCH-8110 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about IHCH-8110 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of IHCH-8110

In research: IHCH-8110 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses IHCH-8110 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: IHCH-8110 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 5-HT2B antagonists, 5-HT2C agonists, Amines, so understanding it makes those chapters shorter.
In everyday life: Look for IHCH-8110 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “IHCH-8110” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study IHCH-8110 in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what IHCH-8110 means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain IHCH-8110 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is IHCH-8110 in simple terms?

IHCH-8110 is a peripherally selective and non-hallucinogenic serotonin 5-HT2A receptor agonist. Pharmacology IHCH-8110 shows affinity for the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors (Ki = 48 nM, 102 nM, and 302 nM, respectively).

Why does IHCH-8110 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study IHCH-8110?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on IHCH-8110.